Aditya Ravi - Krebs Biochemicals Head Vizag
| KREBSBIO | 104.14 8.79 7.78% |
Executive
Aditya Ravi is Head Vizag of Krebs Biochemicals and
| Address | Kothapalli Village, Visakhapatnam, India, 531031 |
| Phone | 91 91 2114 4984 |
| Web | https://krebsbiochem.com |
Krebs Biochemicals Management Efficiency
The company has return on total asset (ROA) of (0.0532) % which means that it has lost $0.0532 on every $100 spent on assets. This is way below average. Krebs Biochemicals' management efficiency ratios could be used to measure how well Krebs Biochemicals manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Krebs Biochemicals' Intangible Assets are increasing as compared to previous years.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Rahul Prakash | Praxis Home Retail | N/A | |
| Venugopal Nair | Praxis Home Retail | 55 | |
| Vaishali Thakkar | Praxis Home Retail | N/A | |
| Vikash Kabra | Praxis Home Retail | N/A | |
| Ketan Gandhalikar | Praxis Home Retail | N/A | |
| Juergen Hase | Reliance Communications Limited | N/A | |
| Mukul Chandra | Praxis Home Retail | 39 | |
| Rakesh Gupta | Reliance Communications Limited | 48 | |
| Samir Kedia | Praxis Home Retail | 44 | |
| Braham Singh | Reliance Communications Limited | N/A | |
| Prakash Gokarn | Reliance Communications Limited | N/A | |
| Smita Chowdhury | Praxis Home Retail | N/A | |
| Navin Mudbhatkal | Praxis Home Retail | ||
| Ashish Bhutda | Praxis Home Retail | N/A | |
| Sanu Kapoor | Praxis Home Retail | N/A | |
| Prashant Barfe | Praxis Home Retail | 46 | |
| Bhavesh Singla | Hemisphere Properties India | 32 | |
| Lubna | Hemisphere Properties India | 31 | |
| Srinivasan Gopalan | Reliance Communications Limited | 56 | |
| Armando Eduarte | Praxis Home Retail | 48 | |
Management Performance
| Return On Asset | -0.0532 |
Krebs Biochemicals and Leadership Team
Elected by the shareholders, the Krebs Biochemicals' board of directors comprises two types of representatives: Krebs Biochemicals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Krebs. The board's role is to monitor Krebs Biochemicals' management team and ensure that shareholders' interests are well served. Krebs Biochemicals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Krebs Biochemicals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rakesh Kalbate, Company Officer | ||
| Aditya Ravi, Head Vizag | ||
| Sudhir Manne, Head Nellore | ||
| Keyur Doshi, Company Officer | ||
| Ritesh Jain, Chief Officer | ||
| Ravi Babu, Chief Officer | ||
| Jitendra Shah, CEO MD | ||
| Pabitra Bhattacharya, MD Director |
Krebs Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Krebs Biochemicals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.0532 | ||||
| Profit Margin | (0.37) % | ||||
| Operating Margin | (0.30) % | ||||
| Current Valuation | 4.18 B | ||||
| Shares Outstanding | 21.56 M | ||||
| Shares Owned By Insiders | 77.55 % | ||||
| Price To Sales | 4.27 X | ||||
| Revenue | 504.21 M | ||||
| Gross Profit | 244.19 M | ||||
| EBITDA | (82.73 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Krebs Stock
Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.